MC
CVS icon

Mathes Company’s CVS Health CVS Stock Holding History

Mathes Company’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-11,500
Closed -$785K – 125
2020
Q4 		$785K Hold
11,500
– – 0.32% 76
2020
Q3 		$672K Sell
11,500
-400
-3% -$24.9K 0.31% 75
2020
Q2 		$773K Sell
11,900
-100
-0.8% -$6.3K 0.38% 71
2020
Q1 		$712K Sell
12,000
-2,500
-17% -$167K 0.47% 60
2019
Q4 		$1.08M Sell
14,500
-3,000
-17% -$211K 0.5% 57
2019
Q3 		$1.1M Hold
17,500
– – 0.57% 50
2019
Q2 		$954K Buy
17,500
+3,250
+23% +$175K 0.51% 59
2019
Q1 		$769K Buy
14,250
+5,400
+61% +$333K 0.39% 68
2018
Q4 		$580K Hold
8,850
– – 0.37% 73
2018
Q3 		$697K Sell
8,850
-4,400
-33% -$315K 0.33% 75
2018
Q2 		$853K Buy
+13,250
New +$873K 0.41% 67
2017
Q4 		– Sell
-4,684
Closed -$381K – 144
2017
Q3 		$381K Sell
4,684
-1,325
-22% -$105K 0.18% 106
2017
Q2 		$483K Sell
6,009
-4,725
-44% -$373K 0.23% 91
2017
Q1 		$843K Sell
10,734
-2,100
-16% -$168K 0.45% 60
2016
Q4 		$1.01M Buy
12,834
+200
+2% +$16.2K 0.56% 53
2016
Q3 		$1.12M Buy
12,634
+1,900
+18% +$179K 0.64% 46
2016
Q2 		$1.03M Sell
10,734
-60
-0.6% -$5.98K 0.6% 48
2016
Q1 		$1.12M Buy
10,794
+2,556
+31% +$249K 0.67% 43
2015
Q4 		$805K Buy
8,238
+4,000
+94% +$392K 0.46% 64
2015
Q3 		$409K Sell
4,238
-160
-4% -$16.8K 0.27% 86
2015
Q2 		$461K Hold
4,398
– – 0.25% 96
2015
Q1 		$454K Hold
4,398
– – 0.23% 108
2014
Q4 		$424K Buy
4,398
+810
+23% +$71.4K 0.22% 111
2014
Q3 		$286K Hold
3,588
– – 0.14% 141
2014
Q2 		$270K Hold
3,588
– – 0.13% 151
2014
Q1 		$269K Sell
3,588
-90
-2% -$6.36K 0.14% 144
2013
Q4 		$263K Buy
+3,678
New +$236K 0.14% 143

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mathes Company's CVS Position: Q1 2021 in Review

Mathes Company sold out of CVS Health (CVS) in Q1 2021, closing a stake of 11,500 shares — an estimated $785K sold.

Mathes Company first reported a position in CVS in Q4 2013 and held it in 27 quarters. The position peaked at $1.12M in Q3 2016. 2,032 funds tracked by Wall St. Rank hold CVS as of Q1 2021.

  • Mathes Company reported no remaining CVS Health position as of Q1 2021 after selling out during the quarter.
  • Mathes Company sold 11,500 CVS Health shares in Q1 2021, an estimated $785K.
  • Mathes Company first reported a position in CVS Health in Q4 2013 and held it in 27 quarters.
  • Mathes Company's CVS Health position peaked at $1.12M in Q3 2016.
  • 2,032 funds tracked by Wall St. Rank held CVS Health as of Q1 2021.

Based on Mathes Company's 13F filing for Q1 2021, filed 28 Apr 2021.